feed,title,long_url,short_url
Benzinga,Celsion's Ovarian Cancer Immunotherapy Shows 41% Improvement In R0 Resection Rates,https://benzinga.com/general/biotech/21/04/20444997/celsions-ovarian-cancer-immunotherapy-shows-41-improvement-in-r0-resection-rates,https://j.mp/2Obb9RF
